FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Jubilant Cadista Pharmaceuticals Pantoprazole Sodium Delayed-Release Tablets Recall

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Man…

Jubilant Cadista Pharmaceuticals, Inc. · Salisbury, MD

Risk level
Class II
Reported by FDA
Oct 17, 2018
Recall ID
D-0011-2019
Check your lot numberHow we source this data

Summary

Jubilant Cadista Pharmaceuticals recalled Pantoprazole Sodium Delayed-Release Tablets starting Oct 2, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0011-2019 on Oct 17, 2018. Reason: Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets. Status: Terminated.

Why it was recalled

Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.

Product description

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

Lot numbers, UPCs & expiration codes

Lot #: PA26038A, Exp 04/19; PA26039A, PA26040A, PA26050A, Exp 05/19; PA26052A, Exp 06/19; PA26073A, Exp 07/19; PA217071A, PA217072A, PA217073B, PA217074B, Exp 06/20; PA217101A, Exp 08/20; and PA218023A, Exp 01/21.

Where it was sold

Product was distributed Nationwide in the USA and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0011-2019
Classification
Class II
Status
Terminated
Recall initiated
Oct 2, 2018
FDA report date
Oct 17, 2018
Quantity
158,466 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0011-2019, exactly as published.

Show all FDA fields
City
Salisbury
State
MD
Status
Terminated
Country
United States
Event ID
81162
Address
207 Kiley Dr
Code information
Lot #: PA26038A, Exp 04/19; PA26039A, PA26040A, PA26050A, Exp 05/19; PA26052A, Exp 06/19; PA26073A, Exp 07/19; PA217071A, PA217072A, PA217073B, PA217074B, Exp 06/20; PA217101A, Exp 08/20; and PA218023A, Exp 01/21.
Postal code
21801-2249
Report date
Oct 17, 2018
Product type
Drugs
Recall number
D-0011-2019
Classification
Class II
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
Product quantity
158,466 bottles
Termination date
Feb 24, 2020
Reason for recall
Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.
Distribution pattern
Product was distributed Nationwide in the USA and Puerto Rico.
Recall initiation date
Oct 2, 2018
Initial firm notification
Letter
Center classification date
Oct 9, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0011-2019, published Oct 17, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls